Tazorac

Active Ingredient(s): Tazarotene
FDA Approved: * June 13, 1997
Pharm Company: * ALLERGAN
Category: Skin Care

Tazarotene, sold under the brand name Tazorac, among others, is a third-generation prescription topical retinoid.[1][2] It is primarily used for the treatment of plaque psoriasis and acne.[3] Tazarotene is also used as a therapeutic for photoaged and photodamaged skin.[3] Tazarotene is a member of the acetylenic class of retinoids.[3] Contents 1 Medical uses 1.1 Pregnancy 2 Contraindications 3 Adverse effects... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Tazorac 1 mg/g Cutaneous Gel
NDC: 0023-0042
Labeler:
Allergan, Inc.
Tazorac 1 mg/g Cutaneous Gel
NDC: 0023-3090
Labeler:
Allergan, Inc.
Tazorac .5 mg/g Cutaneous Gel
NDC: 0023-3091
Labeler:
Allergan, Inc.
Tazorac .5 mg/g Cutaneous Gel
NDC: 0023-8335
Labeler:
Allergan, Inc.
Tazorac .5 mg/g Cutaneous Cream
NDC: 0023-9155
Labeler:
Allergan, Inc.
Tazorac 1 mg/g Cutaneous Cream
NDC: 0023-9156
Labeler:
Allergan, Inc.
Tazorac 1 mg/g Cutaneous Gel
NDC: 16110-042
Labeler:
Almirall, LLC
Tazorac .5 mg/g Cutaneous Gel
NDC: 16110-833
Labeler:
Almirall, LLC
Tazorac .05 mg/g Cutaneous Cream
NDC: 16110-915
Labeler:
Almirall, LLC
Tazorac .1 mg/g Cutaneous Cream
NDC: 16110-916
Labeler:
Almirall, LLC

Related Brands

Drugs with the same active ingredients